Ligand Pharmaceuticals appoints Nancy Ryan Gray to board
Dr. Gray currently serves as President and Chief Executive Officer of Gordon Research Conferences.
Prior to joining Gordon Research Conferences in 2003, for nine years Dr. Gray was with the American Chemical Society (ACS) in Washington, D.C., the world’s largest scientific society, most recently as Director of Membership.
Dr. Gray also was the liaison to the Board Committee on Grants and Awards and the Council Committee on Nominations and Elections, and was responsible for the ACS national election process.
Prior to joining the ACS, she spent nine years as a Senior Research Scientist at Exxon/Mobil Research and Engineering (formerly Exxon Production Research) in Houston.
Dr. Gray is a Fellow of the Royal Society of Chemistry, a Fellow of the American Association for the Advancement of Science and a member of the American Chemical Society.
She received a B.S. in chemistry from the University of Notre Dame and a Ph.D. in Fuel Chemistry from The Pennsylvania State University.
Dr. Gray was a Research Fellow at the Foundation on Matter Institute for Atomic and Molecular Physics in Amsterdam, and completed the Harvard Executive Education Finance for Senior Executives program. She also has authored or co-authored numerous scientific articles. ■
LATEST MOVES FROM California
- Twitter appoints Patrick Pichette to board
- eBay appoints two to board
- Cisco executive chairman John Chambers to step down
- Wesco Aircraft Holdings appoints Kerry A. Shiba as CFO
- Achaogen appoints Liz Bhatt as CBO
More inside POST
How many mistakes you should tolerate Leadership